Form D · Other
Catterton StriVectin Investment Company, LLC
Greenwich, CT · CIK 0001468879
Offering snapshot reported Jul 23, 2009 · SEC filing
- Reported sold
- $12.4M Offering amount: $12.9M
- Investors reported
- 4 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jul 10, 2009 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jul 23, 2009 | Initial | $12,350,101 | No comparison | 4 | SEC filing |
Offering details
- Securities
- Not reported
- Exemptions
- 06
- Duration over one year
- No
- Business combination
- Yes
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-133050
Source: Form D, filed Jul 23, 2009. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| David Delmore | Director |
| Richard D. Gersten | Director, Executive |
| Jonathan H. Owsley | Director, Executive |
| Stephen Powell | Director, Executive |
| Thomas Stemberg | Director |
Issuer details
Industry: Other (See others in industry)
Address:
Co Catterton Partners 7 Greenwich Office Park, Suite 200, 599 West Putnam
Greenwich, CT, 06830
Greenwich, CT, 06830